Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Arthroscopic Treatment Combined With PRP for Refractory Elbow Epicondylitis
NCT04556825Active, not recruiting
- Sponsor
- Beijing Jishuitan Hospital
- Start
- Jul 2020
- Primary completion
- Jul 2024
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Randomised trial of platelet-rich plasma in Lateral Epicondylitis (LET) (2 arms), sponsored by Beijing Jishuitan Hospital. Primary endpoint: Mayo Elbow Performance Score at 24 months. Started Jul 2020; status: active, not recruiting.
02
Drugs
platelet-rich plasma
03
Conditions
Lateral Epicondylitis (LET)
Beyond the preview
Go deeper on NCT04556825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04556825.